Role of nanocarrier-based inhalation L-type calcium channel modulators with antioxidant role to support cardiac myocyte

In India, over 80% of cardiovascular disease (CVD) deaths result from ischemic heart disease and stroke. Here, Radhakrishnan et al., describe their study aiming to develop nanoparticle-based inhalational L-type calcium channel modulators to support the failing cardiac myocyte. Download now to discover how the study provides proof of concept for an innovative, safe, and efficient personalized inhalational medicine for a failing heart that is designed to prevent the progression of heart failure.